(2S,1S)-METHYL-1-[1-(N-BUTYLCARBAMOYL)-1-METHYL-1-PHENYLMETHYL]-PYRROLIDINE-2-CARBOXYLATE
Compound with spectra: 1 NMR
![(2S,1S)-METHYL-1-[1-(N-BUTYLCARBAMOYL)-1-METHYL-1-PHENYLMETHYL]-PYRROLIDINE-2-CARBOXYLATE](/api/compound/1l5QkWq1vsQ.png?ph=true&h=300&w=458 "(2S,1S)-METHYL-1-[1-(N-BUTYLCARBAMOYL)-1-METHYL-1-PHENYLMETHYL]-PYRROLIDINE-2-CARBOXYLATE")
| SpectraBase Compound ID | 1l5QkWq1vsQ |
|---|---|
| InChI | InChI=1S/C19H28N2O3/c1-4-5-13-20-18(23)19(2,15-10-7-6-8-11-15)21-14-9-12-16(21)17(22)24-3/h6-8,10-11,16H,4-5,9,12-14H2,1-3H3,(H,20,23)/t16-,19-/m0/s1 |
| InChIKey | FLWGJSOTRTYRAG-LPHOPBHVSA-N |
| Mol Weight | 332.44 g/mol |
| Molecular Formula | C19H28N2O3 |
| Exact Mass | 332.209993 g/mol |
| Enantiomer InChIKey | FLWGJSOTRTYRAG-VQIMIIECSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(2S,1R)-1-[1-(TERT.-BUTYLCARBAMOYL)-1-METHYL-1-PHENYLMETHYL]-PYRROLIDINE-2-CARBOXYLATE
(4R,8AS)-4-METHYL-4-PHENYL-PERHYDROPYRROLO-[1,2-A]-PYRAZINE-1,3-DIONE
[corr1](2S,4S)- and (2S,4R)-1-[(S)-2-Benzylamino-1-phenethyl]-2,4-bis(tert-butoxycarbonyl)pyrrolidine
(2R,4R)- and (2R,4S)-1-[(R)-2-Benzylamino-1-phenethyl]-2,4-bis(tert-butoxycarbonyl)pyrrolidine
5-ETHYLCARBAMOYL-5-PHENYL-1-PROPYLHYDANTOIN
(3R,5S,6R)-3,4,5-trimethyl-3,6-diphenyl-2-morpholinone
(2S)-2-[[2-(tert-butylamino)-1-(2-diphenylphosphinophenyl)-2-keto-ethyl]amino]-3-methyl-butyric acid methyl ester
METHYL-(2R,ALPHA-S)-ALPHA-(2-CARBAMOYL-2-METHYL-5-OXO-PYRROLIDIN-1-YL)-ALPHA-PHENYLACETATE
METHYL-(2S,ALPHA-S)-ALPHA-(2-CARBAMOYL-2-METHYL-5-OXO-PYRROLIDIN-1-YL)-ALPHA-PHENYLACETATE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of New Perhydropyrrolo[1,2-a]pyrazine Derivatives and Their Evaluation in Animal Models of Epilepsy | Molecules | 2014 |